Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems

被引:24
作者
Fuster, Daniel [1 ,2 ]
Cheng, Debbie M. [1 ,2 ,3 ]
Quinn, Emily K. [4 ]
Nunes, David [5 ,6 ]
Saitz, Richard [1 ,2 ,7 ]
Samet, Jeffrey H. [1 ,2 ,8 ]
Tsui, Judith I. [1 ,2 ]
机构
[1] Boston Med Ctr, Gen Internal Med Sect, Dept Med, Clin Addict Res & Educ CARE Unit, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[4] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA
[5] Boston Med Ctr, Dept Med, Gastroenterol Sect, Boston, MA 02118 USA
[6] Boston Univ, Sch Med, Boston, MA 02118 USA
[7] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[8] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA
关键词
Hepatitis C; HIV; mortality; alcohol; HUMAN-IMMUNODEFICIENCY-VIRUS; SUSTAINED VIROLOGICAL RESPONSE; INJECTION-DRUG USERS; MINI-MENTAL-STATE; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE; CLINICAL PROGRESSION; TERM MORTALITY; INCREASED RISK; COINFECTION;
D O I
10.1111/add.12367
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
AimsTo assess the association between hepatitis C virus (HCV) infection and overall and liver-related death in human immunodeficiency virus (HIV)-infected patients with alcohol problems. DesignWe analyzed data from a cohort of HIV-infected adults with current or past alcohol problems enrolled between 2001 and 2003, searching for causes of death until 2010 using the National Death Index. Setting and participantsParticipants were HIV-infected adults with current or past alcohol problems, recruited in Boston, MA from HIV clinics at two hospitals, homeless shelters, drug treatment programs, subject referrals, flyers and another cohort study with comparable recruitment sites. MeasurementsThe primary and secondary outcomes were all-cause and liver-related mortality, respectively. The main independent variable was hepatitis C virus (HCV) RNA status (positive versus negative). Mortality rates and Kaplan-Meier survival curves were calculated by HCV status for both overall and liver-related mortality. Cox proportional hazards models were used to assess the association between HCV infection and overall and liver-related death, adjusting for alcohol and drug use over time. FindingsA total of 397 adults (50% HCV-infected) were included. As of 31 December 2009, 83 cohort participants had died (60 HCV-infected, 23 HCV-uninfected; log-rank test P<0.001), and 26 of those deaths were liver-related (21 HCV-infected, five HCV-uninfected; log-rank test P<0.001). All-cause and liver-related mortality rates were 4.68 and 1.64 deaths per 100 person-years for HCV-infected patients and 1.65 and 0.36 per 100 person-years for those without HCV, respectively. In the fully adjusted Cox model, HCV infection was associated with both overall [hazard ratio (HR)=2.55, 95% confidence interval (CI)=1.50-4.33, P<0.01], and liver-related mortality (HR=3.24, 95% CI=1.18-8.94, P=0.02]. ConclusionHepatitis C virus infection is associated independently with all-cause and liver-related mortality in human immunodeficiency virus-infected patients with alcohol problems, even when accounting for alcohol and other drug use.
引用
收藏
页码:62 / 70
页数:9
相关论文
共 55 条
[1]   Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study [J].
Amin, Janaki ;
Law, Matthew G. ;
Bartlett, Mark ;
Kaldor, John M. ;
Dore, Gregory J. .
LANCET, 2006, 368 (9539) :938-945
[2]  
Backus LI, 2005, JAIDS-J ACQ IMM DEF, V39, P613
[3]   Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients [J].
Bedimo, R. ;
Westfall, A. O. ;
Mugavero, M. ;
Drechsler, H. ;
Khanna, N. ;
Saag, M. .
HIV MEDICINE, 2010, 11 (07) :462-468
[4]   Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy [J].
Berenguer, Juan ;
Alejos, Belen ;
Hernando, Victoria ;
Viciana, Pompeyo ;
Salavert, Miguel ;
Santos, Ignacio ;
Gomez-Sirvent, Juan L. ;
Vidal, Francesc ;
Portilla, Joaquin ;
Del Amo, Julia .
AIDS, 2012, 26 (17) :2241-2246
[5]   Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus [J].
Berenguer, Juan ;
Rodriguez, Elena ;
Miralles, Pilar ;
Von Wichmann, Miguel A. ;
Lopez-Aldeguer, Jose ;
Mallolas, Josep ;
Galindo, Maria J. ;
Van Den Eynde, Eva ;
Tellez, Maria J. ;
Quereda, Carmen ;
Jou, Antoni ;
Sanz, Jose ;
Barros, Carlos ;
Santos, Ignacio ;
Pulido, Federico ;
Guardiola, Josep M. ;
Ortega, Enrique ;
Rubio, Rafael ;
Jusdado, Juan J. ;
Montes, Maria L. ;
Gaspar, Gabriel ;
Esteban, Herminia ;
Bellon, Jose M. ;
Gonzalez-Garcia, Juan .
CLINICAL INFECTIOUS DISEASES, 2012, 55 (05) :728-736
[6]   Sustained Virological Response to Interferon Plus Ribavirin Reduces Liver-Related Complications and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus [J].
Berenguer, Juan ;
Alvarez-Pellicer, Julio ;
Miralles Martin, Pilar ;
Lopez-Aldeguer, Jose ;
Angel Von-Wichmann, Miguel ;
Quereda, Carmen ;
Mallolas, Josep ;
Sanz, Jose ;
Tural, Cristina ;
Maria Bellon, Jose ;
Gonzalez-Garcia, Juan .
HEPATOLOGY, 2009, 50 (02) :407-413
[7]   Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection [J].
Bica, I ;
McGovern, B ;
Dhar, R ;
Stone, D ;
McGowan, K ;
Scheib, R ;
Snydman, DR .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :492-497
[8]   Mortality in Hepatitis C Virus-Infected Patients With a Diagnosis of AIDS in the Era of Combination Antiretroviral Therapy [J].
Branch, Andrea D. ;
Van Natta, Mark L. ;
Vachon, Marie-Louise ;
Dieterich, Douglas T. ;
Meinert, Curtis L. ;
Jabs, Douglas A. .
CLINICAL INFECTIOUS DISEASES, 2012, 55 (01) :137-144
[9]   Hepatitis C Virus Infection and the Risk of Coronary Disease [J].
Butt, Adeel A. ;
Wang Xiaoqiang ;
Budoff, Matthew ;
Leaf, David ;
Kuller, Lewis H. ;
Justice, Amy C. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (02) :225-232
[10]   High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities [J].
Campbell, JV ;
Hagan, H ;
Latka, MH ;
Garfein, RS ;
Golub, ET ;
Coady, MH ;
Thomas, DL ;
Strathdee, SA .
DRUG AND ALCOHOL DEPENDENCE, 2006, 81 (03) :259-265